NOD2 and Cowden disease: Brain et al showed that miRNA-29 downregulates IL-23 production by targeting its subunit p40.81 It is also known that dendritic cells from NOD2 homogeneous or heterogeneous CD patients are associated with failure to induce miRNA-29 resulting in increased production of IL23, which is currently a clinical therapeutic target in CD therapy.